̽��ֱ�� of Cambridge - Ruth Cameron

Professor Ruth Cameron receives Suffrage Science award on the scheme’s tenth anniversary

sc604 — Mon, 08 Mar 2021 14:28:19 +0000

Ten years ago, Professor Dame Amanda Fisher, Director of the MRC London Institute of Medical Sciences (then Clinical Sciences Centre), and Vivienne Parry OBE, science writer and broadcaster, concocted an idea to celebrate the contributions that women scientists have made to their field, sometimes overlooked in favour of their male counterparts. With an endorsement from Dr Helen Pankhurst CBE, women’s rights activist and great-granddaughter of Emmeline Pankhurst, they called the awards scheme Suffrage Science.

Their awards were hand-crafted items of jewellery created by art students from Central Saint Martins-UAL, who worked with scientists to design pieces inspired by research and by the Suffragette movement. But rather than produce a new set of pieces for the next awards, each holder chose who they would like to pass their award onto, thus generating an extensive ‘family tree’ of incredible scientists and communicators.

As the relay continued, new branches of the Suffrage Science scheme were developed – the Engineering and Physical Sciences strand was founded in 2013, and the ‘Maths and Computing’ strand followed in 2016. ̽��ֱ��Suffrage Science family is now 148 strong, with a further 12 joining on Monday 8 March 2021, the tenth anniversary of the scheme.

Each previous holder chose to whom they wanted to pass their ‘heirloom’ piece of jewellery.

Professor Serena Best from Cambridge’s Department of Materials Science and Metallurgy, who was honoured in 2020, chose to pass her award to her colleague Professor Ruth Cameron. She said: “Professor Ruth Cameron is a highly successful and respected scientist in the field of biomaterials whose organisational abilities and communication skills are outstanding. Most recently, she has become the first female appointee to lead the Department of Materials Science and Metallurgy, ̽��ֱ�� of Cambridge in the Office of Head of Department. Ruth’s work ethic will provide inspiration to the next generation of young female scientists - demonstrating that the key to success is collegial support and collaboration.”

Professor Róisín Owens from Cambridge’s Department of Chemical Engineering and Biotechnology, and Professor Melinda Duer from the Yusuf Hamied Department of Chemistry, were also named winners in 2020. Owens has chosen to pass her award to Professor Natalie Stingelin from Georgia Institute of Technology, and Duer has chosen to pass her award to Dr Mary Anti Chama from the ̽��ֱ�� of Ghana.

“Natalie is a tremendous advocate for diversity in science and engineering,” said Owens. “She was incredibly supportive of me when I started out, mentoring me and suggesting my name for conferences and editorial work. She has worked tirelessly to support women and is very active on social media. She has brought countless young researchers, especially women under her wing, helping them to develop their careers. She is also very proactive in getting the old guard to be inclusive and diverse – including calling out conference organisers for not including women in their speaker lists. In her role as editor at RSC she has been very involved in trying to improve diversity and equality in publishing also.”

“I have known Mary since she was a Cambridge-Africa Research Fellow in Cambridge,” said Duer. “She impressed me then with how she approached interdisciplinary science, and brought in whatever techniques she needed in her quest to find new pharmaceutical compounds in plants. She has continued to impress me as she has developed her science and brought in new collaborators. She has been a champion for women in science throughout her career and very supportive of students and younger colleagues alike. I hope she won't mind my saying that she also ensured that all her siblings had access to higher education - and now continues that with ensuring that her graduate students have what they need to be successful. I always enjoy any discussion with Mary - she has shown me how one can be kind, compassionate and still be ambitious in one's science.”

Suffrage Science pioneer Professor Fisher said: “We dreamed up the awards scheme to celebrate the contribution that women have made to science, which often gets overlooked. This is as important now as it was ten years ago. This year’s awardees join a community of over 148 women scientists. I’m thrilled that since 2011, the awards have travelled from the UK, across Europe to the USA, Hong Kong, Iran and to Ghana, illustrating the international nature of science and engineering, and the global effort to improve the representation of women in STEM.”

Professor Ruth Cameron from Cambridge’s Department of Materials Science & Metallurgy is one of twelve winners of this year’s Suffrage Science awards. She and the other winners will be honoured at an online celebration today, the tenth anniversary of the scheme. This will be the fifth Suffrage Science awards for engineering and physical sciences.

Ruth’s work ethic will provide inspiration to the next generation of young female scientists

Serena Best

Ruth Cameron

̽��ֱ��text in this work is licensed under a Creative Commons Attribution 4.0 International License. Images, including our videos, are Copyright © ̽��ֱ�� of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – as here, on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

Yes

Patching up a broken heart

lw355 — Fri, 16 Jun 2017 15:00:54 +0000

When the body’s repair system kicks in, in an attempt to remove the dead heart cells, a thick layer of scar tissue begins to form. While this damage limitation process is vital to keep the heart pumping and the blood moving, the patient’s problems have really only just begun.

Cardiac scar tissue is different to the rest of the heart. It doesn’t contract or pump because it doesn’t contain any new heart muscle cells. Those that are lost at the time of the heart attack never come back. This loss of function weakens the heart and, depending on the size of the damaged area, affects both the patient’s quality of life and lifespan.

“In many patients, not only is their heart left much weaker than normal but they are unable to increase the amount of blood pumped around the body when needed during exercise,” explains Dr Sanjay Sinha. “I’ve just walked up a flight of stairs… it’s something I take for granted but many patients who’ve survived heart attacks struggle to do even basic things, like getting dressed. While there are treatments that improve the symptoms of heart failure, and some even improve survival to a limited extent, none of them tackles the underlying cause – the loss of up to a billion heart cells.”

̽��ֱ��numbers are stark. “Half a million people have heart failure in the UK. Almost half of them will not be alive in five years because of the damage to their heart. At present, the only way to really improve their heart function is to give them a heart transplant. There are only 200 heart transplants a year in the UK – it’s a drop in the ocean when many thousands need them.”

Sinha wants to mend these hearts so that they work again. “Not just by a few percent improvement but by a hundred percent.”

He leads a team of stem cell biologists in the Cambridge Stem Cell Institute. Over the past five years, with funding from the British Heart Foundation, they have been working with materials scientists Professors Ruth Cameron and Serena Best and biochemist Professor Richard Farndale on an innovative technique for growing heart patches in the laboratory – with the aim of using these to repair weakened cardiac tissue.

“In the past, people have tried injecting cardiomyocytes into damaged hearts in animal models and shown that they can restore some of the muscle that’s been lost,” says Sinha. “But even in the best possible hands, ninety percent of the cells you inject are lost because of the hostile environment.”

Instead, the Cambridge researchers are building tiny beating pieces of heart tissue in Petri dishes. ̽��ֱ��innovation that makes this possible is a scaffold. “ ̽��ֱ��idea is to make a home for heart cells that really suits them to the ground. So they can survive and thrive and function.”

̽��ֱ��scaffold is made of collagen – a highly abundant protein in the animal kingdom. Best and Cameron are experts at creating complex collagen-based structures for a variety of cell types – bone marrow, breast cancer, musculoskeletal – both as implants and as model systems to test new therapeutics.

“ ̽��ֱ��technology we’ve developed for culturing cells is exciting because it is adaptable to a huge range of applications – almost any situation where you’re trying to regenerate new tissue,” explains Best.

Best and Cameron use ‘ice-templating’ to build the scaffold. They freeze a solution of collagen, water and certain biological molecules. When the water crystals form, they push the other molecules to their boundaries. So, when the crystals are vapourised (by dropping the pressure to low levels), what’s left is a complex three-dimensional warren.

“We have immense control over this structure,” adds Cameron. “We can vary the pore structure to make cells align in certain orientations and control the ratios of cell types. We are building communities of millions of cells in an environment that resembles the heart.”

Cardiomyocytes fare better when they are surrounded by other cell types and have something to hold on to. They use proteins on their surface called integrins to touch, stick to and communicate with their environment. Farndale has perfected a ‘toolkit’ that pinpoints exactly which parts of collagen the integrins bind best; he then makes matching peptide fragments to ‘decorate’ the collagen scaffold. This gives cells a foothold in the scaffold and encourages different cell types to move in and populate the structure.

“We don’t just want a cardiac scaffold – we want it to have blood vessels and the same mechanical properties as the heart,” explains Sinha. “If it’s going to contract and function efficiently, it needs a really good blood supply. And the whole three-dimensional structure must be strong enough to survive the hostile environment of a damaged heart.”

Meanwhile, Sinha’s team pioneered the production of the different cell types needed for the patch. Their starting material is human embryonic stem cells, but they have also taken adult human cells and ‘reset’ their developmental clock. “In theory this means we can take a patient’s own cells and make patches that are identical to their own tissue. That said, millions of people are going to need this sort of therapy and so our focus at the moment is on coming up with a system where a small number of patches might be available ‘off the shelf’, with patients receiving the nearest match.

̽��ֱ��team is completing tests on the ideal combination of scaffold structure, peptide decoration and mix of cells to create a beating vascularised tissue. Next, the researchers will work with Dr Thomas Krieg in the Department of Medicine to graft the tissue into a rat heart. Their aim is to show that the patch makes vascular connections, integrates mechanically and electrically with heart muscle, and contracts in synchrony with the rest of the heart. Once they’ve accomplished this, they will scale up the size of the patches for future use in people.

“It’s exciting,” says Sinha. “We are recreating a tissue that has all the components we see in an organ, where the cells start talking together in mysterious and wonderful ways, and they start to work together as they do in the body. Our vision is that this technology will bring hope to the millions of patients worldwide who are suffering from heart failure, and allow them to lead a normal life again.”

It is almost impossible for an injured heart to fully mend itself. Within minutes of being deprived of oxygen – as happens during a heart attack when arteries to the heart are blocked – the heart’s muscle cells start to die. Sanjay Sinha wants to mend these hearts so that they work again.

We are recreating a tissue that has all the components we see in an organ, where the cells start talking together in mysterious and wonderful ways, and they start to work together as they do in the body.

Sanjay Sinha

̽��ֱ��District and Jonathan Settle

̽��ֱ��text in this work is licensed under a Creative Commons Attribution 4.0 International License. For image use please see separate credits above.

Yes

Celebrating 10 years of European research excellence

ag236 — Mon, 13 Mar 2017 12:40:43 +0000

When European government representatives met in Lisbon in the year 2000, and expressed an aspiration that Europe should become the world's leading knowledge economy by 2010, they agreed on the need to create a body to “fund and co-ordinate basic research at European level”.

This was the impetus underlying the creation, in 2007, of the European Research Council (ERC).

Ten years after its foundation, the ERC has become a European success story. It has supported some 6,500 projects through its prestigious grants, and has become a unique model for the fostering and funding of innovative academic research.

To mark the anniversary, events are being held across Europe during ERC Week, running from 13-19 March. At the ̽��ֱ�� of Cambridge, various recipients of ERC grants will be sharing their findings with a wide audience in talks scheduled as part of the Cambridge Science Festival.

̽��ֱ��McDonald Institute for Archaeological Research will be joining in ERC Week celebrations by hosting a conference on Thursday, 16 March.

On the same day, a reception for Cambridge recipients of ERC grants, attended by ERC president Prof. Jean-Pierre Bourguignon, will be held at the Fitzwilliam Museum, which is currently showing the ERC-supported exhibition, “Madonnas and Miracles: ̽��ֱ��Holy Home in Renaissance Italy”.

̽��ֱ��ERC supports outstanding researchers in all fields of science and scholarship. It awards three types of research awards (Starter, Consolidator, Advanced) through a competitive, peer-reviewed process that rewards excellence. Its focus on “frontier research” allows academics to develop innovative and far-reaching projects over five-year periods.

̽��ֱ��United Kingdom has been the largest recipient of ERC awards –between 2007 and 2015, it received 24% of all ERC funding.

To date, the ERC has supported 1524 projects by UK-based academics. Researchers at the ̽��ֱ�� of Cambridge have won 218 of those grants, in fields ranging from Astronomy to Zoology.

“What is special about an ERC grant?”, asks Dr Marta Mirazón Lahr, who was awarded an ERC Advanced Investigator Award for her project “IN-AFRICA”, which examines the evolution of modern humans in East Africa.

“An obvious side is that it’s a lot of money. But I think it’s more than just the money. Because it’s five years, the ERC grant allows you to get a group and build a real community around the project. It also allows you to explore things in greater depth.”

An ERC grant allowed Dr Debora Sijacki, at the Institute of Astronomy, to attract “a really competitive and international team, which otherwise would have been almost impossible to get.”

Being funded for a five-year period, she adds, “gives you time to expand and really tackle some of the major problems in astrophysics, rather than doing incremental research.”

It also allowed her access to facilities: “In my case, it was access to world-leading supercomputers. And without the ERC grant this would have been difficult.”

“Real progress in research is made when researchers can tackle big important questions," says Prof David Baulcombe, of the Department of Plant Sciences, the recipient of two ERC grants. " ̽��ֱ��ERC programme invites researchers to submit ambitious, blue-skies, imaginative proposals. There aren’t many others sources of funding that allow one to do that sort a thing.”

Dr Christos Lynteris, of the Centre for Research in the Arts, Humanities and Social Sciences (CRASSH), is the recipient of an ERC Starting Grant for his project “Visual representations of the third plague pandemic.

“An ERC is a unique opportunity," he says: “it fosters interdisciplinary work. It also fosters analytical tools and the creation of new methods.”

“It offers a great opportunity to work with other people, over a period of 5 years, which is something very unusual, and with quite a liberal framework, so you are able to change and shift your questions, to reformulate them. For me, it means freedom, above everything.”

For Prof. Ottoline Leyser, Director of the Sainsbury Laboratory, it is the “ERC ethos” and its “emphasis on taking things in new directions” that has made all the difference.

̽��ֱ��ERC values an innovative, risk-taking approach “in a way that conventional grant-funding schemes don’t –they usually want to see that slow build rather than the risky step into the unknown.”

Prof. Simon Goldhill, Director of CRASSH, was awarded an ERC Advanced Investigator Award for his project “Bible and Antiquity in 19th Century Culture”. It has given him “the unique opportunity to do a genuinely interdisciplinary collaborative project with the time and space it takes to make such interdisciplinarity work.”

“Most importantly,” he adds, “the financial model offered by this sort of project enables us to do work that is 15 or 20 years ahead of the rest of the world, and Britain and Europe are all the stronger for it.”

̽��ֱ��sentiment is echoed by Prof. Ruth Cameron, of the Department of Materials Science and Metallurgy. ̽��ֱ��impact of an ERC grant for her project “3D Engineered Environments for Regenerative Medicine” has, she says, “exceeded expectations”.

So what has the ERC ever done for us? Quite a lot, say Cambridge academics, as they mark the 10th anniversary of Europe’s premier research-funding body

̽��ֱ��financial model offered by this sort of project enables us to do work that is 15 or 20 years ahead of the rest of the world. Britain and Europe are all the stronger for it.

Prof. Simon Goldhill, CRASSH

Cambridge & the ERC: 10 years of research excellence

̽��ֱ��text in this work is licensed under a Creative Commons Attribution 4.0 International License. For image use please see separate credits above.

Yes

Body builders: collagen scaffolds

lw355 — Wed, 04 Jun 2014 09:07:30 +0000

It may not look like much to the naked eye, but collagen is remarkably strong. ̽��ֱ��most abundant protein in the animal kingdom, it gives strength and structure to skin, tendons, ligaments, smooth muscle tissue and many other parts of the body.

Through precise manipulation at a structural level, collagen can also be used as a construction material in the laboratory or clinic to help regenerate new tissue, repair damaged cartilage and bone, or aid in the development of new therapies for cardiac disease, blood disorders and cancer.

To understand these conditions better and develop new treatments, or regenerate new tissue, researchers require models that very closely mimic the complex, three-dimensional environments found in human tissue.

As a natural material, collagen is ideal for these biomimetic applications. By shaping it into porous structures, collagen acts as a ‘scaffold’ on which cells and tissue can grow in three dimensions in predetermined forms, mimicking those found in the body.

̽��ֱ��idea of using collagen as a scaffold is not new, but the very high level of control that Cambridge researchers are able to achieve over its properties has made a huge range of clinical applications possible, including the repair of damaged joints or tissue, or accelerating the development of new therapies for cancer.

“There is an increasing need for improved materials that work with the systems in the body to regenerate healthy tissue, rather than just replacing what’s there with something synthetic,” said Professor Ruth Cameron of the Department of Materials Science and Metallurgy, who, along with Professor Serena Best, is working with researchers from across the ̽��ֱ�� to develop the scaffolds for a range of clinical applications. “You’re trying to help the body to heal itself and produce what it needs in order to do that.”

To build the scaffolds, the researchers begin with a solution of collagen and water and freeze it, creating ice crystals. As the collagen cannot incorporate into ice, it gathers around the edges of the crystals. When the pressure around the ice is dropped to very low levels, it converts directly from a solid to vapour, leaving the collagen structure behind. By precisely controlling how the ice crystals grow as the water freezes, the researchers are able to control the shape and properties of the resulting collagen scaffold.

By adding small groups of amino acids known as peptide sequences to the surface of the scaffold at different points, the way in which the collagen interacts with the growing cells changes, altering the potential uses for the scaffold. ̽��ֱ��peptide sequences signal certain cells to bind to the scaffold or to each other, while signalling other cells to migrate. Collectively, these signals direct the scaffold to form a certain type of tissue or have a certain type of biological response.

“ ̽��ֱ��scaffolds are a three-dimensional blank canvas – they can then be used in any number of different ways,” said Cameron, who is funded by the European Research Council. “They can be used to mimic the way in which natural tissue behaves, or they can be directed to form different sized or sequenced structures.”

̽��ֱ��technology has already gone from the laboratory all the way to patients, first as Chondromimetic, a product for the repair of damaged knee joints and bone defects associated with conditions such as osteoarthritis, trauma or surgery. By adding calcium and phosphate to the scaffold to mimic the structure of bone, it helps regenerate bone and cartilage. Chondromimetic has been through clinical trials and has received its CE mark, enabling its sale in Europe.

In future, the scaffolds could also see use as a treatment for cardiac disease. Working with Professor Richard Farndale from the Department of Biochemistry and Dr Sanjay Sinha from the Department of Medicine, and supported by funding from the British Heart Foundation, Best and Cameron are developing the scaffolds for use as patches to repair the heart after a heart attack.

Heart attacks occur when there is an interruption of blood to the heart, killing heart muscle. ̽��ֱ��remaining heart muscle then has to work harder to pump blood around the body, which can lead to a thickening of the heart wall and potential future heart failure.

By modifying the collagen scaffolds with the addition of peptide sequences, they could be used to grow new heart cells to ‘patch’ over areas of dead muscle, regenerating the heart and helping it function normally. Cells could be taken directly from the patient and reprogrammed to form heart cells through stem cell techniques.

While the work is still in its early stages, the scaffolds could one day be an important tool in treating coronary heart disease, which is the UK’s biggest killer. “These scaffolds give cells a foothold,” said Farndale, who is working with Sinha to characterise the scaffolds so that they encourage heart cells to grow. “Eventually, we hope to be able to use them, along with cells we’ve taken directly from the patient, to enable the heart to heal itself following cardiac failure.”

Another potentially important application for the scaffolds is in breast cancer research. By using them to grow mimics of breast tissue, the scaffolds could help accelerate the development of new therapies. Working with Professor Christine Watson in the Department of Pathology, Best and Cameron are fine-tuning the scaffolds so that they can be used to create three-dimensional models of breast tissue. If successful, this artificial breast tissue could assist with the screening of new drugs for breast cancer, reduce the number of animals used in cancer research and ultimately lead to personalised therapies.

“This is a unique culture system,” said Watson. “We are able to add different types of cells to the scaffold at different times, which no-one else can do. Better models will make our work as cancer researchers much easier, which will ultimately benefit patients.”

Like breast tissue, blood platelets also require a very specific environment to grow. Dr Cedric Ghevaert of the Department of Haematology is working with Best and Cameron to use the scaffold technology to create a bone-like niche to grow bone marrow cells, or megakaryocytes, for the production of blood platelets from adult stem cells. In theory, this could be used to produce platelets as and when they are needed, without having to rely on blood donations.

“ ̽��ֱ��technology for culturing the cells is actually quite generic, so the range of applications it could be used for in future is quite broad,” said Best. “In terms of clinical applications, it could be used in almost any situation where you’re trying to regenerate tissue.”

“In some senses, it can be used for anything,” added Cameron. “As you start to create highly organised structures made up of many different types of cells – such as the liver or pancreas – there is an ever-increasing complexity. But the potential of this technology is huge. It could make a huge difference for researchers and patients alike.”

Miniature scaffolds made from collagen – the ‘glue’ that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair the heart after a heart attack.

We are able to add different types of cells to the scaffold at different times, which no-one else can do

Christine Watson

Jennifer Ashworth

Collagen scaffold imaged using X-ray microtomography to reveal its 3D structure

̽��ֱ��text in this work is licensed under a Creative Commons Licence. If you use this content on your site please link back to this page. For image rights, please see the credits associated with each individual image.

Yes